1,202
Participants
Start Date
May 23, 2024
Primary Completion Date
February 3, 2025
Study Completion Date
February 3, 2025
Influenza ModRNA Vaccine
Intramuscular injection
Quadrivalent Influenza Vaccine (QIV)
Intramuscular injection
Rochester Clinical Research, LLC, Rochester
DM Clinical Research - Philadelphia, Philadelphia
Charlottesville Medical Research, Charlottesville
Alliance for Multispecialty Research, LLC, Norfolk
M3 Wake Research, Inc., Raleigh
Duke Vaccine and Trials Unit, Durham
Clinical Neuroscience Solutions, Inc., Orlando
Headlands Research Orlando, Orlando
Indago Research & Health Center, Inc, Hialeah
Palm Springs Community Health Center, Miami Lakes
Research Centers of America ( Hollywood ), Hollywood
Research Centers of America, Hollywood
Qps-Mra, Llc, South Miami
Alliance for Multispecialty Research, LLC, Mobile
Prism Research LLC dba Nucleus Network, Saint Paul
Clinical Research Professionals, Chesterfield
Alliance for Multispecialty Research, LLC, Kansas City
Alliance for Multispecialty Research, LLC, New Orleans
SMS Clinical Research, Mesquite
Dynamed Clinical Research, LP d/b/a DM Clinical Research, Tomball
Clinical Trials of Texas, LLC dba Flourish Research, San Antonio
Clinical Trials of Texas, LLC, San Antonio
Headlands Horizons LLC, Brownsville
J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City
J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City
Headlands Research - Scottsdale, Scottsdale
Artemis Institute for Clinical Research, San Diego
Orange County Research Center, Lake Forest
Anaheim Clinical Trials, LLC, Anaheim
Diablo Clinical Research, Inc., Walnut Creek
East-West Medical Research Institute, Honolulu
Clinical Research Consulting, Milford
Lead Sponsor
Pfizer
INDUSTRY